Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDCD1 | Q15116 | 5/20 | 0.44 |
| ▸ | CD274 | Q9NZQ7 | 5/20 | 0.44 |
| ▸ | USP30 | Q70CQ3 | 2/20 | 0.43 |
| ▸ | UCHL1 | P09936 | 1/20 | 0.43 |
| ▸ | CYP11B2 | P19099 | 12/20 | 0.43 |
| ▸ | CYP11B1 | P15538 | 9/20 | 0.43 |
| ▸ | AR | P10275 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31635535 | 1.00 | PDCD1 (0.44) | PDCD1CD274USP30UCHL1CYP11B2 | |
| SCHEMBL30774625 | 0.92 | USP30 (0.49) | PDCD1CD274USP30UCHL1CYP11B2 | |
| SCHEMBL30774399 | 0.90 | CYP11B2 (0.51) | PDCD1CD274USP30UCHL1CYP11B2 | |
| SCHEMBL30774532 | 0.89 | USP30 (0.46) | USP30UCHL1CYP11B2CYP11B1 | |
| SCHEMBL33532547 | 0.88 | SLC22A12 (0.50) | PDCD1CD274USP30UCHL1CYP11B2 | |
| SCHEMBL30774426 | 0.87 | CYP11B2 (0.48) | PDCD1CD274USP30UCHL1CYP11B2 | |
| SCHEMBL30774475 | 0.87 | USP30 (0.46) | PDCD1CD274USP30UCHL1CYP11B2 | |
| SCHEMBL30774411 | 0.85 | KDM1A (0.47) | PDCD1CD274USP30UCHL1CYP11B2 | |
| SCHEMBL30774401 | 0.84 | CYP11B2 (0.44) | PDCD1CD274USP30UCHL1CYP11B2 | |
| SCHEMBL30774363 | 0.83 | CYP11B2 (0.55) | PDCD1CD274USP30UCHL1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024061371-A1 | ANNELATED PYRIDINE STEROID SYNTHETASE INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF | 广州威诺森医药科技有限公司 | 2024-03-28 | — | — | WO | disclosed |